SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

SunTrust Robinson Humphrey Maintains Buy on Amedisys, Raises Price Target to $240

SunTrust Robinson Humphrey maintains Amedisys (NASDAQ:AMED) with a Buy and raises the price target from $225 to $240.

Benzinga · 05/21/2020 12:46

SunTrust Robinson Humphrey maintains Amedisys (NASDAQ:AMED) with a Buy and raises the price target from $225 to $240.